AMOXIL

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Cyprus, Ecuador, Ireland, Lithuania, Malta, Mexico, New Zealand, Nigeria, Singapore, South Africa, Tunisia.

Active ingredients

The drug AMOXIL contains one active pharmaceutical ingredient (API):

1	Amoxicillin UNII 804826J2HU - AMOXICILLIN
	Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death.
	Read more about Amoxicillin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
AMOXIL Capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CA04	Amoxicillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11947T, 11998L, 1884E, 1886G, 1887H, 1888J, 1889K, 3300Q, 3301R, 3302T, 3310F, 3393N, 9714G
BR	Câmara de Regulação do Mercado de Medicamentos	510600604119314, 510600605115312, 510600606111310, 510613020049703, 510613020049803, 510613020049903, 510619040060503, 510619040060603
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28909-06-09, 29133-01-10, 29185-02-10
IE	Health Products Regulatory Authority	70440, 90522, 90735
LT	Valstybinė vaistų kontrolės tarnyba	1004134, 1033593, 1033594, 1057512, 1057513, 1057514
MT	Medicines Authority	MA192/03101, MA192/03201, PI908/25901A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	133M99, 208M99
NG	Registered Drug Product Database	04-2402, 04-2481, 04-2508
Switch country to Nigeria in order to find specific presentations of AMOXIL
NZ	Medicines and Medical Devices Safety Authority	1687, 1688
SG	Health Sciences Authority	01897P
TN	Direction de la Pharmacie et du Médicament	9093351, 9093352, 9093353
US	FDA, National Drug Code	61919-041, 61919-135, 61919-716
ZA	Health Products Regulatory Authority	E/20.1.2/75, J/20.1.2/29